Glintborg, B, Jensen, D V, Terslev, L, Hendricks, O, Østergaard, M, Rasmussen, S H, Jensen, M P, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Sørensen, C M, Krogh, N S, Agerbo, J N, Ziegler, C & Hetland, M L 2022, ' Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases ', Journal of Rheumatology, vol. 49, no. 10, pp. 1163-1172 . https://doi.org/10.3899/jrheum.211280
Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, e002560 . https://doi.org/10.1136/rmdopen-2022-002560 Nabi, H, Hetland, M L, Loft, A G, Hendricks, O, Jensen, D, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Grydehøj, J, Raun, J, Ahmed, R, Mehnert, F, Krogh, N S & Glintborg, B 2022, ' INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCHING IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: CLINICAL OUTCOMES IN REAL-WORLD PATIENTS FROM THE DANBIO REGISTRY ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0065, pp. 45-46 . https://doi.org/10.1136/annrheumdis-2022-eular.2306 Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD Open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560 Nabi, H, Hendricks, O, Jensen, D V, Loft, A G, Pedersen, J K, Just, S A, Danebod, K, Munk, H L, Kristensen, S, Manilo, N, Colic, A, Linauskas, A, Thygesen, P H, Christensen, L B, Kalisz, M H, Lomborg, N, Chrysidis, S, Raun, J L, Andersen, M, Mehnert, F, Krogh, N S, Hetland, M L & Glintborg, B 2022, ' Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease : Clinical outcomes in real-world patients from the DANBIO registry ', RMD open, vol. 8, no. 2, 002560 . https://doi.org/10.1136/rmdopen-2022-002560
Kopp, T I, Delcoigne, B, Arkema, E V, Magyari, M, Locht, H, Sellebjerg, F T, Cordtz, R L, Jensen, D V, Askling, J & Dreyer, L 2022, ' Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al ', Annals of the Rheumatic Diseases, vol. 81, no. 5, e74, pp. E74 . https://doi.org/10.1136/annrheumdis-2020-217802
Glintborg, B, Jensen, D V, Terslev, L, Jensen, M P, Hendricks, O, Østergaard, M, Engel, S, Rasmussen, S H, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Sørensen, C M, Krogh, N S, Agerbo, J N, Ziegler, C & Hetland, M L 2021, ' Impact of the COVID-19 pandemic on treat to target strategies and physical consultations in > 7000 patients with inflammatory arthritis ', Rheumatology, vol. 60, no. SI, pp. SI3-SI12 . https://doi.org/10.1093/rheumatology/keab500 BASE-Bielefeld Academic Search Engine Rheumatology (Oxford, England) Glintborg, B, Jensen, D V, Terslev, L, Pfeiffer Jensen, M, Hendricks, O, Østergaard, M, Engel, S, Horskjær Rasmussen, S, Adelsten, T, Colic, A, Danebod, K, Kildemand, M, Loft, A G, Munk, H L, Pedersen, J K, Østgård, R D, Møller Sørensen, C, Krogh, N S, Nørgaard Agerbo, J, Ziegler, C & Hetland, M L 2021, ' Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis ', Rheumatology (Oxford, England), vol. 60, no. SI, pp. SI3-SI12 . https://doi.org/10.1093/rheumatology/keab500
Kopp, T I, Delcoigne, B, Arkema, E V, Jacobsen, R K, Magyari, M, Ibfelt, E H, Locht, H, Sellebjerg, F, Cordtz, R L, Jensen, D V, Askling, J & Dreyer, L 2020, ' Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors : a collaborative population-based cohort study from Denmark and Sweden ', Annals of the Rheumatic Diseases, vol. 79, no. 5, pp. 566-572 . https://doi.org/10.1136/annrheumdis-2019-216693